跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 91,967 条关于
“relapsing-remitting disease”
全部
91,967
临床试验
69,245
药物
1,452
机构
166
资讯
21,104
9个月前
Lupin Receives Tentative FDA Approval for Generic Siponimod Multiple Sclerosis Treatment
去年
TG Therapeutics to Present New BRIUMVI Data in Multiple Sclerosis at ACTRIMS 2025 Forum
去年
Zydus and Synthon Partner to Launch Generic Multiple Sclerosis Drug in $637 Million US Market
2年前
Kesimpta Demonstrates Sustained Efficacy in Relapsing Multiple Sclerosis
2年前
BRIUMVI Rapid Infusion Shows Promise in Multiple Sclerosis Treatment
去年
CivicaScript Launches Low-Cost Generic Dimethyl Fumarate for Multiple Sclerosis Treatment
14天前
India's SEC recommends Phase 3 trial waiver for Roche's subcutaneous ocrelizumab in multiple sclerosis
6个月前
TG Therapeutics Secures $500 Million Credit Facility to Fuel BRIUMVI Growth and Pipeline Development
去年
TG Therapeutics' Briumvi Exceeds Expectations, Eyes Subcutaneous Formulation and Azer-Cel Trial in MS
8个月前
Rituximab Shows Long-Term Effectiveness with Extended Dosing Intervals in Relapsing Multiple Sclerosis
第 1 页，共 2111 页
上一页
下一页
